Skip to main content

3 October 2022

Last updated: Friday 30 September 2022

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Why pharma is paying a premium for assets

Sunday 18 March 2018

Interviewee/Contributor

Tim Sturgeon and Martin Gouldstone

Organisation

Results Healthcare

The Trump impact on healthcare M&A

Monday 24 April 2017

Interviewee/Contributor

Tim Sturgeon

Organisation

Results Healthcare

Organisations

Altheia Science Srl
Novasecta Ltd
SFL Regulatory Affairs & Scientific Communication
Arecor Ltd
BioTop
Cellzome
Life Sciences Partners BV
ETH Zürich
TiGenix NV
Autifony Therapeutics Ltd

Interviewees and Contributers

Philippe Villain-Guillot
Jon Rees
Michael Nowak
William Ellington
Emanuel Björne
Ralf Schmid and Emma Harvey
Stanislas Veillet
Robert Mansfield
Jonathan Frampton
Marisa Papaluca-Amati

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Gerald McMahon becomes CEO at STORM Therapeutics

Saturday 17 September 2022

Macomics names Valérie Méresse Naegelen as advisor

Saturday 17 September 2022

Fiona Marshall to lead Novartis research centre

Saturday 17 September 2022

Rob Quinn appointed CFO at Pharnext

Saturday 17 September 2022

Tim Demuth to head R&D at MorphoSys

Saturday 17 September 2022

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2022 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form